FDA Recalls TIROSINT Levothyroxine Sodium Oral Solution for Subpotency
IBSA Pharma Inc. voluntarily recalled specific lots of TIROSINT (levothyroxine sodium) Oral Solution nationwide due to subpotency. The affected medication contains less active ingredient than labeled.
- Product
- TIROSINT — TIROSINT (LEVOTHYROXINE SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide